AI assistant
ELI LILLY & Co — Board/Management Information 2009
Jun 2, 2009
29745_rns_2009-06-02_d9ec2d20-53e7-4b24-ac7f-0d7e0f47f91e.zip
Board/Management Information
Open in viewerOpens in your device viewer
8-K 1 htm_33008.htm LIVE FILING CoverPageHeader start html PUBLIC "-//W3C//DTD HTML 3.2//EN" Eli Lilly and Company (Form: 8-K) Comment1
CoverPageHeader end CoverPageTitle START
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): May 29, 2009
CoverPageTitle END CoverPageRegistrant START
Eli Lilly and Company ______ (Exact name of registrant as specified in its charter)
| Indiana | 001-06351 | 35-0470950 |
|---|---|---|
| ___ (State or other jurisdiction | _______ (Commission | __ (I.R.S. Employer |
| of incorporation) | File Number) | Identification No.) |
| Lilly Corporate Center, Indianapolis, Indiana | 46285 | |
| _________ (Address of principal executive offices) | _____ (Zip Code) |
Registrants telephone number, including area code: 317-276-2000
Not Applicable __________ Former name or former address, if changed since last report
CoverPageRegistrant END
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
PageBreak START
Top of the Form
PageBreak END Item START
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 29, 2009, the Board of Directors of Eli Lilly and Company elected R. David Hoover as a new member, effective June 1, 2009. Hoover, 63, currently serves as chairman, president, and chief executive officer of Ball Corporation. As a member of the Lilly board, Hoover will serve on the board’s audit and compensation committees. He will serve under interim election and will stand for election by Lilly shareholders at the company’s annual meeting in 2010. Mr. Hoover has served as chairman, president, and CEO of Ball Corporation since April 2002 and as president and CEO since January 2001. He joined Ball Corporation in 1970 and served in various leadership positions. He was elected senior vice president and chief financial officer in 1992. He was named executive vice president and elected to the company's board of directors in 1996. In 1998 he was elected vice chairman, in addition to the role of chief financial officer. Mr. Hoover became president of Ball Corporation on January 2000, and was named chief operating officer in April 2000. Mr. Hoover is a member of the boards of Energizer Holdings, Inc.; Qwest Communications International Inc.; and Irwin Financial Corporation.
Item END
PageBreak START
Top of the Form
PageBreak END SignatureHeader START
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SignatureHeader END Signature START
| James B. Lootens |
|---|
| Name: James B. Lootens |
| Title: Secretary and Deputy General Counsel |
Signature END HTMLFooter START HTMLFooter END